Press Release

Cooley Advises Underwriters on Immune Design IPO

August 11, 2014

New York – August 11, 2014 – Cooley LLP announced today that it advised the underwriters on Immune Design Corp.'s $63 million IPO. Immune Design is a clinical-stage immunotherapy company with next-generation approaches designed to enable the body's immune system to fight disease. The company trades on The NASDAQ Global Market under the symbol "IMDZ."

Jefferies LLC and Leerink Partners LLC acted as the joint book-running managers and Wells Fargo Securities, LLC acted as the lead manager for the offering.

The Cooley corporate securities team advising the underwriters included partners Div Gupta, David Peinsipp and Charlie Kim, and associates Carolyn Mo, Kristin VanderPas and Pia Kaur. Critical support for the offering was provided by partners Natasha Leskovsek and Wendy Goldstein, special counsel Phil Mitchell and associate Jennifer Shanley (health care and life sciences regulatory); partner Bill Christiansen (intellectual property); partner Renee Deming and associate Justin Ho (compensation and benefits); and partner Susan Philpot (tax).

Thus far in 2014, Cooley has advised on 73 public offerings, including 37 completed IPOs.

About Cooley LLP

Cooley's attorneys solve legal issues for entrepreneurs, investors, financial institutions and established companies. Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and bet-the-company litigation, often where innovation meets the law.

Cooley has more than 750 lawyers across 11 offices in the United States and China.

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.